doi:10.1007/s10565-011-9203-9
Blockbuster obesity and diabetes drugs such as Wegovy, Ozempic, and Mounjaro are no longer deemed by regulators to be in shortage, so compounding pharmacies and the telehealth companies they work with must stop offering copies of the treatments
If you have diabetes and notice vision changes, contact your ophthalmologist
Two GLP-1 agents appeared in the second round of price negotiations in 20242025
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes
Compared with conventional GLP-1 receptor agonists, such as liraglutide and semaglutide, tirzepatide has demonstrated superior efficacy in body weight control in several phase III clinical trials, with average weight reductions exceeding 20% in some study populations (15)